 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | 177Lu-P17-088 / Five Eleven Pharma, Peking Union Medical College, 177Lu-P17-087 / Five Eleven Pharma, Peking Union Medical College
Trial completion, Metastases: 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - Oct 23, 2023
P1, N=9, Completed, Sponsor: Peking Union Medical College Hospital
Not yet recruiting --> Completed
- | 177Lu-P17-088 / Five Eleven Pharma, Peking Union Medical College, 177Lu-P17-087 / Five Eleven Pharma, Peking Union Medical College
New P1 trial, Metastases: 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - Nov 2, 2022
P1, N=10, Not yet recruiting, Sponsor: Peking Union Medical College Hospital